Suppr超能文献

[1985年抗微生物剂对从尿路感染分离出的病原体的活性比较研究。III. 敏感性的长期变化]

[Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1985). III. Secular changes in susceptibility].

作者信息

Kosakai N, Kumamoto Y, Sakai S, Hirose T, Okayama S, Shigeta S, Shiraiwa Y, Yoshida H, Miura Y, Ogata M

机构信息

Juntendo University Urayasu Hospital.

出版信息

Jpn J Antibiot. 1987 Dec;40(12):2026-142.

PMID:3448256
Abstract

Sensitivities to antimicrobial agents of Escherichia coli, Klebsiella spp., Citrobacter spp., Enterobacter spp., Proteus spp., Pseudomonas aeruginosa and Serratia marcescens isolated from infected patients were evaluated and compared according to the types of their infections, i.e., simple and complicated urinary tract infections with or without indwelling catheter. There were no apparent decreases in the sensitivity of E. coli isolated from patients with simple urinary tract infections. When data obtained in 1982-1985 were summarized, it was found that a new quinoline derivative, ofloxacin (OFLX), showed the strongest activity among oral antimicrobial and antibiotic agents. This agent inhibited 100% of bacterial growth at MIC of 1.56 micrograms/ml. The next strongest activity was found with mecillinam (MPC) which showed 89.3% growth inhibition at the same concentration. Cefaclor (CCL) also showed 84.9% growth inhibition at the same concentration. When sensitivities of E. coli isolated from patients with complicated urinary tract infections with or without indwelling catheter to first and second generation cephems were determined, cefotiam (CTM), which inhibited 88.9%: 91.4% bacterial growth at MIC of 0.39 micrograms/ml, had the strongest activity among CTM, cefazolin (CEZ), cefoxitin (CFX) and cefmetazole (CMZ). Among third generation cephems, including cefmenoxime (CMX), latamoxef (LMOX), ceftizoxime (CZX), cefotaxime (CTX) and cefoperazone (CPZ), the strongest activity was observed with CZX, and the agent having the next strongest activity was CMX. LMOX and CPZ showed relatively low activities. Carumonam (CRMN) and aztreonam (AZT), monobactams, showed strong activities against E. coli. As for Klebsiella spp., activities of pencillins against these strains were low. When activities of oral cephems (cephalexin (CEX) and CCL) and of a quinoline derivative OFLX against these strains were determined, OFLX showed strong activity; i.e., the growth of Klebsiella spp. isolated from complicated urinary tract infections was inhibited at 87.2%: 82.1% at MIC of 0.20 micrograms/ml.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

对从感染患者中分离出的大肠杆菌、克雷伯菌属、柠檬酸杆菌属、肠杆菌属、变形杆菌属、铜绿假单胞菌和粘质沙雷氏菌对抗菌药物的敏感性,根据其感染类型进行了评估和比较,即有无留置导管的单纯性和复杂性尿路感染。从单纯性尿路感染患者中分离出的大肠杆菌的敏感性没有明显下降。当总结1982 - 1985年获得的数据时,发现一种新的喹啉衍生物氧氟沙星(OFLX)在口服抗菌药物和抗生素中显示出最强的活性。该药物在1.56微克/毫升的最低抑菌浓度(MIC)下可抑制100%的细菌生长。其次是美西林(MPC),在相同浓度下显示出89.3%的生长抑制率。头孢克洛(CCL)在相同浓度下也显示出84.9%的生长抑制率。当测定从有或无留置导管的复杂性尿路感染患者中分离出的大肠杆菌对第一代和第二代头孢菌素的敏感性时,头孢替安(CTM)在0.39微克/毫升的MIC下抑制88.9%: 91.4%的细菌生长,在CTM、头孢唑林(CEZ)、头孢西丁(CFX)和头孢美唑(CMZ)中活性最强。在第三代头孢菌素中,包括头孢甲肟(CMX)、拉氧头孢(LMOX)、头孢唑肟(CZX)、头孢噻肟(CTX)和头孢哌酮(CPZ),CZX活性最强,其次是CMX。LMOX和CPZ活性相对较低。碳青霉烯类抗生素卡芦莫南(CRMN)和氨曲南(AZT)对大肠杆菌显示出较强的活性。至于克雷伯菌属,青霉素对这些菌株的活性较低。当测定口服头孢菌素(头孢氨苄(CEX)和CCL)和喹啉衍生物OFLX对这些菌株的活性时,OFLX显示出较强的活性;即从复杂性尿路感染中分离出的克雷伯菌属在0.20微克/毫升的MIC下生长抑制率为87.2%: 82.1%。(摘要截于400字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验